The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Osiris Therapeutics Inc

Nasdaq: OSIR
Last

(U.S.) $18.00

Today's change-0.73 -3.90%
Updated August 31 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

Osiris Therapeutics Inc

Nasdaq: OSIR
Last

(U.S.) $18.00

Today's change-0.73 -3.90%
Updated August 31 4:00 PM -4GMT. Delayed by at least 15 minutes.

Osiris Therapeutics Inc crosses below 125-day moving average

Osiris Therapeutics Inc closed sharply lower Monday, dropping (U.S.)$0.73 or 3.90% to (U.S.)$18.00 and crossing below its 125-day moving average. Over the last five days, shares have gained 5.76% and 12.57% year to date. Shares have outperformed the S&P 500 by 27.52% during the last year.

Key company metrics

  • Open(U.S.) $18.68
  • Previous close(U.S.) $18.73
  • High(U.S.) $19.05
  • Low(U.S.) $17.97
  • Bid / Ask(U.S.) $17.65 / (U.S.) $20.00
  • YTD % change+12.57%
  • Volume248,763
  • Average volume (10-day)206,206
  • Average volume (1-month)257,466
  • Average volume (3-month)191,471
  • 52-week range(U.S.) $11.87 to (U.S.) $23.67
  • Beta0.88
  • Trailing P/E144.20×
  • P/E 1 year forward89.19×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.12
Updated August 31 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.04%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue24211917
Total other revenue--------
Total revenue24211917
Gross profit19161513
Total cost of revenue5544
Total operating expense22191816
Selling / general / administrative15131011
Research & development2241
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--000
Operating income2211
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax2211
Income after tax1111
Income tax, total0100
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment--00--
Diluted weighted average shares35353435
Diluted EPS excluding extraordinary itemsvalue per share0.030.040.030.02
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share0.030.040.030.02